Stem cell shot aims to tame MS in Drug-Resistant patients
Disease control
Ongoing
This early-stage study tests a single dose of IMS001, a stem cell therapy made from human embryonic cells, in 30 adults with multiple sclerosis (MS) who did not get better with standard treatments. The main goal is to check if the treatment is safe and tolerable. Researchers will…
Phase: PHASE1 • Sponsor: ImStem Biotechnology • Aim: Disease control
Last updated May 07, 2026 18:41 UTC